BSEM - BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors | Benzinga
POMPANO BEACH, Fla., Dec. 19, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces it has appointed Mr. Patrick Daly to its Board of Directors.
Mr. Daly is an award-winning executive leader with a strong track record of success in operations, strategy, sales, marketing, fundraising, and partnership-building.
BioStem Technologies CEO, Jason Matuszewski, said, "We are excited to welcome Patrick Daly to BioStem's Board of Directors and look forward to leveraging his deep industry experience and relationships in the Biomaterials and MedTech market segments."
Mr. Daly is an Advisor at Pappas Capital, a private equity firm focused on the life sciences industry. Most recently, he served as Global VP Commercial Solutions and subsequently, Global VP MedTech Data Delivery, at IQVIA Holdings and was responsible for leading a global strategic MedTech Commercial Solutions business unit.
Previously, he held the position of President and CEO at Cohera Medical, an early-stage commercial-stage life sciences company developing biomaterials for surgical adhesives, sealants, and drug delivery products that was acquired by global investment firm, KKR. At Cohera, Mr. Daly spearheaded the development of a novel delivery device for synthetic surgical adhesive that maintained a two-year shelf life and received the Businesswire 2012 Medical Design Excellence Award.
Mr. Daly also held leadership positions for more than a decade at Johnson & Johnson.
Mr. Daly commented, "I am honored to contribute to BioStem's dynamic journey. The company's strategic positioning in expanding markets, particularly in ...